載入...
Demonstrating Analytical Similarity of Trastuzumab Biosimilar HLX02 to Herceptin(®) with a Panel of Sensitive and Orthogonal Methods Including a Novel FcγRIIIa Affinity Chromatography Technology
BACKGROUND: A biosimilar needs to demonstrate its similarity to the originator reference product (RP) in terms of structural and functional properties as well as nonclinical and clinical outcomes. OBJECTIVES: The aim was to assess the analytical similarity between the trastuzumab biosimilar HLX02 an...
Na minha lista:
| 發表在: | BioDrugs |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer International Publishing
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7211197/ https://ncbi.nlm.nih.gov/pubmed/32072477 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40259-020-00407-0 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|